Summarising salient information on historical controls: A structured assessment of validity and comparability across studies

Reducing Patient Burden in Clinical Trials Through the Use of Historical Controls: Appropriate Selection of Historical Data to Minimize Risk of Bias

(2020) Jessica Lim et al.   Therapeutic Innovation & Regulatory Science

How to use prior knowledge and still give new data a chance?

(2018) Kristina Weber et al.   PHARMACEUTICAL STATISTICS

Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials

(2018) Jessica Lim et al.   Therapeutic Innovation & Regulatory Science

Modified power prior with multiple historical trials for binary endpoints

(2018) Akalu Banbeta et al.   STATISTICS IN MEDICINE

Covariate-adjusted borrowing of historical control data in randomized clinical trials

(2017) Baoguang Han et al.   PHARMACEUTICAL STATISTICS

A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint

(2017) G. Frank Liu   PHARMACEUTICAL STATISTICS

Including historical data in the analysis of clinical trials: Is it worth the effort?

(2017) Joost van Rosmalen et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Modelling Comparative Efficacy of Drugs with Different Survival Profiles: Ipilimumab, Vemurafenib and Dacarbazine in Advanced Melanoma

(2016) D. Lee et al.   BIODRUGS

Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials

(2016) Ludovic Trinquart et al.   JOURNAL OF CLINICAL ONCOLOGY

Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and Taxonomy

(2016) Anthony J. Hatswell et al.   PHARMACOECONOMICS

Extrapolation of efficacy and other data to support the development of new medicines for children: A systematic review of methods

(2016) Ian Wadsworth et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014

(2016) Anthony J Hatswell et al.   BMJ Open

Robust meta-analytic-predictive priors in clinical trials with historical control information

(2014) Heinz Schmidli et al.   BIOMETRICS

Clinical and prognostic factors for melanoma of the skin using SEER registries: Collaborative stage data collection system, version 1 and version 2

(2014) Carol L. Kosary et al.   CANCER

Comparison of anticipated and actual control group outcomes in randomised trials in paediatric oncology provides evidence that historically controlled studies are biased in favour of the novel treatment

(2014) Veronica Moroz et al.   Trials

Use of historical control data for assessing treatment effects in clinical trials

(2013) Kert Viele et al.   PHARMACEUTICAL STATISTICS

Empirical Evaluation of Very Large Treatment Effects of Medical Interventions

(2012) Tiago V. Pereira et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The network meta-analytic-predictive approach to non-inferiority trials

(2012) Heinz Schmidli et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research

(2012) James E. Signorovitch et al.   VALUE IN HEALTH

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

(2011) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Error Rates in Single-Arm Versus Randomized Phase II Cancer Clinical Trials

(2010) Hui Tang et al.   JOURNAL OF CLINICAL ONCOLOGY

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

(2010) Johann Sebastian de Bono et al.   LANCET

Blinded Independent Central Review of the Progression-Free Survival Endpoint

(2010) O. Amit et al.   ONCOLOGIST

No Head-to-Head Trial? Simulate the Missing Arms

(2010) J. Jaime Caro et al.   PHARMACOECONOMICS

A note on the power prior

(2009) Beat Neuenschwander et al.   STATISTICS IN MEDICINE

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

(2008) David J Kuter et al.   LANCET